BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Drug Establishment Registration and Drug Listing Requirement
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-14073-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260911
DTEND;VALUE=DATE:20260912
SUMMARY:FDA comments close: Drug Establishment Registration and Drug Listi
 ng Requirements for Establishments Engaged in Distributed Manufacturing a
 nd Certain Foreign Establishments
DESCRIPTION:Proposed Rule. Federal Register 2026-14073. Docket FDA-2025-N-
 6075. Details: https://docket-clock.pages.dev/doc/2026-14073/ Official: h
 ttps://www.federalregister.gov/documents/2026/07/13/2026-14073/drug-estab
 lishment-registration-and-drug-listing-requirements-for-establishments-en
 gaged-in
URL:https://www.federalregister.gov/documents/2026/07/13/2026-14073/drug-e
 stablishment-registration-and-drug-listing-requirements-for-establishment
 s-engaged-in
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR